Sugi Predict

Sugi Predict / Compounds / SCHEMBL779452

SCHEMBL779452

SCHEMBL779452

Fc1ccccc1C1CC[CH]CC1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM1A O60341 5/20 0.45
▸ KDM1B Q8NB78 1/20 0.45
▸ KDM4E B2RXH2 1/20 0.43
▸ GAA P10253 1/20 0.43
▸ ADRA1D P25100 1/20 0.40
▸ ADRA1A P35348 1/20 0.40
▸ ADRA1B P35368 1/20 0.40
▸ HTR1A P08908 4/20 0.39
▸ SLC6A2 P23975 4/20 0.39
▸ SLC6A4 P31645 4/20 0.39
▸ SLC6A3 Q01959 3/20 0.39
▸ HTR2C P28335 2/20 0.39
▸ HTR2B P41595 1/20 0.39
▸ GRM2 Q14416 2/20 0.38
▸ DRD2 P14416 1/20 0.38
▸ DRD3 P35462 1/20 0.38
▸ HCAR2 Q8TDS4 1/20 0.36
▸ RCOR1 Q9UKL0 1/20 0.36
▸ DRD4 P21917 1/20 0.35
▸ MEN1 O00255 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL434606 0.86 KDM1A (0.52) KDM1AKDM1BKDM4EGAAADRA1D
SCHEMBL8130316 0.83 HTR2C (0.42) KDM1AKDM1BKDM4EGAAHTR1A
SCHEMBL434672 0.82 KDM4E (0.50) KDM1AKDM1BKDM4EGAAADRA1D
SCHEMBL316350 0.82 KDM4E (0.55) KDM1AKDM1BKDM4EGAAADRA1D
SCHEMBL779602 0.80 GAA (0.42) KDM1AKDM1BKDM4EGAAADRA1D
SCHEMBL128052 0.80 KDM4E (0.53) KDM1AKDM1BKDM4EGAAADRA1D
Ammonia Solution, Strong SCHEMBL17982788 0.80 KDM4E (0.48) KDM1AKDM1BKDM4EGAAADRA1D
SCHEMBL29436912 0.80 KDM4E (0.53) KDM1AKDM1BKDM4EGAAADRA1D
SCHEMBL17068945 0.80 KDM4E (0.53) KDM1AKDM1BKDM4EGAAADRA1D
SCHEMBL30217494 0.78 KDM1A (0.41) KDM1AKDM1BKDM4EGAAADRA1D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220149436-A1 NON-AQUEOUS LIQUID ELECTROLYTE AND NON-AQUEOUS LIQUID ELECTROLYTE SECONDARY BATTERY MITSUBISHI CHEMICAL CORPORATION (JP) 2022-05-12 — — US disclosed
EP-3621141-A1 NON-AQUEOUS LIQUID ELECTROLYTE AND NON-AQUEOUS LIQUID ELECTROLYTE SECONDARY BATTERY MITSUBISHI CHEMICAL CORPORATION (JP) 2020-03-11 — — EP disclosed
US-20190229372-A1 NON-AQUEOUS LIQUID ELECTROLYTE AND NON-AQUEOUS LIQUID ELECTROLYTE SECONDARY BATTERY MITSUBISHI CHEMICAL CORPORATION (JP) 2019-07-25 — — US disclosed
CN-109952300-A As indoleamine 2, imidazo [1,5-a] pyridine of the novel 5 or 8- substitution of 3- dioxygenase enzyme and/or tryptophan 2,3- dioxygenase enzyme selectivity inhibitor 百济神州有限公司 2019-06-28 — — CN disclosed
CN-107244663-B A kind of preparation method of difluorophosphate 江苏国泰超威新材料有限公司 2019-06-25 — — CN disclosed
US-10333172-B2 Non-aqueous liquid electrolyte and non-aqueous liquid electrolyte secondary battery MITSUBISHI CHEMICAL CORPORATION (JP) 2019-06-25 — — US disclosed
US-10290901-B2 — — 2019-05-14 — — US disclosed
CN-105731412-B A kind of preparation method of difluorophosphoric acid salt 中国科学院宁波材料技术与工程研究所 2018-02-23 — — CN disclosed
CN-107244663-A A kind of preparation method of difluorophosphate 江苏国泰超威新材料有限公司 2017-10-13 — — CN disclosed
US-9608291-B2 Non-aqueous liquid electrolyte and non-aqueous liquid electrolyte secondary battery MITSUBISHI CHEMICAL CORPORATION (JP) 2017-03-28 — — US disclosed
US-20090286155-A1 LITHIUM DIFLUOROPHOSPHATE, ELECTROLYTE CONTAINING LITHIUM DIFLUOROPHOSPHATE, PROCESS FOR PRODUCING LITHIUM DIFLUOROPHOSPHATE, PROCESS FOR PRODUCING NONAQUEOUS ELECTROLYTE, NONAQUEOUS ELECTROLYTE, AND NONAQUEOUS ELECTROLYTE SECONDARY BATTERY CONTAINING THE SAME MITSUBISHI CHEMICAL CORPORATION (JP) 2009-11-19 — — US disclosed
CN-101507041-A Lithium difluorophosphate, electrolyte containing lithium difluorophosphate, method for producing nonaqueous electrolyte, and nonaqueous electrolyte secondary battery using same MITSUBISHI CHEM CORP (JP) 2009-08-12 — — CN disclosed
EP-2061115-A1 LITHIUM DIFLUOROPHOSPHATE, ELECTROLYTIC SOLUTION CONTAINING LITHIUM DIFLUOROPHOSPHATE, PROCESS FOR PRODUCING LITHIUM DIFLUOROPHOSPHATE, PROCESS FOR PRODUCING NONAQUEOUS ELECTROLYTIC SOLUTION, NONAQUEOUS ELECTROLYTIC SOLUTION, AND NONAQUEOUS-ELECTROLYTIC-SOLUTION SECONDARY CELL EMPLOYING THE SAME Mitsubishi Chemical Corporation (JP) 2009-05-20 — — EP disclosed
CN-101432923-A Nonaqueous electrolyte solution and nonaqueous electrolyte secondary battery MITSUBISHI CHEM CORP (JP) 2009-05-13 — — CN disclosed
EP-1415986-B1 SPIRO ISOBENZOFURANES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS BANYU PHARMA CO LTD (JP) 2009-04-08 — — EP disclosed
EP-2012386-A1 NONAQUEOUS ELECTROLYTE SOLUTION AND NONAQUEOUS ELECTROLYTE SECONDARY BATTERY Mitsubishi Chemical Corporation (JP) 2009-01-07 — — EP disclosed
US-7205417-B2 Spiro compounds BANYU PHARMACEUTICAL CO., LTD. (JP) 2007-04-17 — — US disclosed
US-20040259890-A1 Spiro compounds MSD K.K. (JP) 2004-12-23 — — US disclosed
CN-1538956-A Spiro compounds ������ҩ��ʽ���� 2004-10-20 — — CN disclosed
EP-1415986-A1 SPIRO COMPOUNDS BANYU PHARMACEUTICAL CO., LTD. (JP) 2004-05-06 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040259890-A1 Spiro compounds OPRD1, PER2, OPRK1 KDM1A 2420/4885KDM1B 2725/4885KDM4E 2787/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.